| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3977963 | Brachytherapy | 2008 | 9 Pages |
Abstract
A modern analysis of eye plaque dosimetry evaluated dose as a function of lesion height and applicator size, and showed dependence on radionuclide selection and implant duration. For a fixed dose at the prescription point, we observed higher scleral dose corresponded with lower photon energy for a variety of plaque sizes and lesion heights.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Mark J. Rivard, Christopher S. Melhus, Shirin Sioshansi, Jody Morr,